title: The presence of anti-Yersinia pseudotuberculosis immunoglobulins in equine serum.
abstract: The research was conducted on clinically healthy mares (n = 40) and foals (n = 78) during Y. pseudotuberculosis associated enzootics. The animals were divided into groups: I to IV--mares, IA to IVA--their offsprings, IB to IVB--foals which mothers were not treated with any medicaments. The animals in group I, IA and IB were injected with PBS; in group II, IIA and IIB--with Y. pseudotuberculosis strain-based vaccine, in group III, IIIA and IIIB--with P. acnes strain-based immunostimulator; in group IV, IVA and IVB--with P. acnes strain-based immunostimulator and (5 days after the immunostimulator injection) Y. pseudotuberculosis strain-based vaccine. The presence of antibodies was determined by means of ELISA. The study revealed anti-Yersinia pseudotuberculosis IgG only in 19 mares before, and in 25 mares and 26 foals 3 weeks after vaccination. The mean extinction 3 weeks after vaccination amounted to: II-0.489, IV-2.578, iiA-0.572, IVA-0.974, IIB-0.312, iVB-0.418. The cut-off extinction value was 0.154. The presence of anti-Yersinia pseudotuberculosis IgG before vaccination in the sera of clinically healthy mares may suggest that Y. pseudotuberculosis infection occurs definitely more often than is expected. Vaccination preceded by immunostimulation appeared to be the most efficient method of treatment against yersiniosis.
authors.affiliation: Department of Immunology, Microbiology and Physiological Chemistry, Faculty of Biotechnology and Animal Sciences, West Pomeranian University of Technology in Szczecin, Doktora Judyma 24, 71-466 Szczecin, Poland.
authors.forename: D
authors.initials: D
authors.lastname: Czernomysy-Furowicz
authors.forename: A
authors.initials: A
authors.lastname: Silecka
authors.forename: P
authors.initials: P
authors.lastname: Nawrotek
authors.forename: D
authors.initials: D
authors.lastname: Jankowiak
authors.forename: J
authors.initials: J
authors.lastname: Karakulska
authors.forename: A
authors.initials: A
authors.lastname: Furowicz
mesh_terms: D000818:Animals; D001428:Bacterial Vaccines / Q000276:immunology; D005260:Female; D006734:Horse Diseases / Q000097:blood / Q000382:microbiology* / Q000517:prevention & control; D006736:Horses; D007112:Immunity, Maternally-Acquired; D007136:Immunoglobulins / Q000097:blood* / Q000276:immunology; D008297:Male; D011247:Pregnancy; D015011:Yersinia pseudotuberculosis / Q000276:immunology*; D015012:Yersinia pseudotuberculosis Infections / Q000097:blood / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary*
chemical_list: D001428:Bacterial Vaccines; D007136:Immunoglobulins